Trial Outcomes & Findings for Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses. (NCT NCT05615935)

NCT ID: NCT05615935

Last Updated: 2025-10-01

Results Overview

A self-development scale, known as the "HIV Testing-Related Knowledge and Practice Scale," is employed to assess individuals' knowledge and practices pertaining to HIV testing. The scale consists of twenty-eight questions, encompassing both True-False and multiple-choice formats. Participants earn one point for each correct answer, contributing to a total score that ranges from the minimum scores of 0 to the maximum scores of 28. Higher scores signify a more positive outcome, indicating enhanced HIV testing-related knowledge and practice among the participants.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

74 participants

Primary outcome timeframe

pre-test(Baseline) and post-test (week 4)

Results posted on

2025-10-01

Participant Flow

Participant milestones

Participant milestones
Measure
Get a Learning Material and a Experiential HIV Testing
These participants in the experimental group will be provided a learning material about HIV testing, then an experiential HIV Testing, which includes HIV testing and counselling, education and discussion, and a post-test interviews will be provided. Experiential HIV Testing: The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.
Get a Learning Material Only
These participants in the control group will be provided a learning material about HIV testing only. After the post-test, the experiential HIV Testing will be provided to them.
Overall Study
STARTED
37
37
Overall Study
COMPLETED
36
36
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Get a Learning Material and a Experiential HIV Testing
These participants in the experimental group will be provided a learning material about HIV testing, then an experiential HIV Testing, which includes HIV testing and counselling, education and discussion, and a post-test interviews will be provided. Experiential HIV Testing: The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.
Get a Learning Material Only
These participants in the control group will be provided a learning material about HIV testing only. After the post-test, the experiential HIV Testing will be provided to them.
Overall Study
Lost to Follow-up
1
1

Baseline Characteristics

Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Get a Learning Material and a Experiential HIV Testing
n=36 Participants
These participants in the experimental group will be provided a learning material about HIV testing, then an experiential HIV Testing, which includes HIV testing and counselling, education and discussion, and a post-test interviews will be provided. Experiential HIV Testing: The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.
Get a Learning Material Only
n=36 Participants
These participants in the control group will be provided a learning material about HIV testing only. After the post-test, the experiential HIV Testing will be provided to them.
Total
n=72 Participants
Total of all reporting groups
Age, Continuous
28.03 years
STANDARD_DEVIATION 4.58 • n=99 Participants
29.14 years
STANDARD_DEVIATION 5.74 • n=107 Participants
28.58 years
STANDARD_DEVIATION 5.19 • n=206 Participants
Sex: Female, Male
Female
28 Participants
n=99 Participants
28 Participants
n=107 Participants
56 Participants
n=206 Participants
Sex: Female, Male
Male
8 Participants
n=99 Participants
8 Participants
n=107 Participants
16 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
36 Participants
n=99 Participants
36 Participants
n=107 Participants
72 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
White
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
Taiwan
36 participants
n=99 Participants
36 participants
n=107 Participants
72 participants
n=206 Participants
education level
bachelor's degree
33 Participants
n=99 Participants
33 Participants
n=107 Participants
66 Participants
n=206 Participants
education level
master's degree
3 Participants
n=99 Participants
3 Participants
n=107 Participants
6 Participants
n=206 Participants
Marital status
married
4 Participants
n=99 Participants
6 Participants
n=107 Participants
10 Participants
n=206 Participants
Marital status
single
32 Participants
n=99 Participants
30 Participants
n=107 Participants
62 Participants
n=206 Participants
Nursing practice years
5.06 years
STANDARD_DEVIATION 4.49 • n=99 Participants
6.18 years
STANDARD_DEVIATION 5.28 • n=107 Participants
5.62 years
STANDARD_DEVIATION 4.90 • n=206 Participants
Nursing practice years in the ED
3.6 years
STANDARD_DEVIATION 3.64 • n=99 Participants
4.77 years
STANDARD_DEVIATION 4.32 • n=107 Participants
4.18 years
STANDARD_DEVIATION 4.01 • n=206 Participants
religion
Buddhism
3 Participants
n=99 Participants
7 Participants
n=107 Participants
10 Participants
n=206 Participants
religion
Taoism
6 Participants
n=99 Participants
6 Participants
n=107 Participants
12 Participants
n=206 Participants
religion
Buddhism and Taoism
1 Participants
n=99 Participants
2 Participants
n=107 Participants
3 Participants
n=206 Participants
religion
Christianity
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
religion
Catholicism
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
religion
None
23 Participants
n=99 Participants
19 Participants
n=107 Participants
42 Participants
n=206 Participants
catastrophic illness
yes
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
catastrophic illness
no
36 Participants
n=99 Participants
35 Participants
n=107 Participants
71 Participants
n=206 Participants
receiving HIV-related lecture in recent 12 months
yes
11 Participants
n=99 Participants
10 Participants
n=107 Participants
21 Participants
n=206 Participants
receiving HIV-related lecture in recent 12 months
no
25 Participants
n=99 Participants
26 Participants
n=107 Participants
51 Participants
n=206 Participants
ever had HIV occupational exposure or not
yes
11 Participants
n=99 Participants
11 Participants
n=107 Participants
22 Participants
n=206 Participants
ever had HIV occupational exposure or not
no
25 Participants
n=99 Participants
25 Participants
n=107 Participants
50 Participants
n=206 Participants

PRIMARY outcome

Timeframe: pre-test(Baseline) and post-test (week 4)

A self-development scale, known as the "HIV Testing-Related Knowledge and Practice Scale," is employed to assess individuals' knowledge and practices pertaining to HIV testing. The scale consists of twenty-eight questions, encompassing both True-False and multiple-choice formats. Participants earn one point for each correct answer, contributing to a total score that ranges from the minimum scores of 0 to the maximum scores of 28. Higher scores signify a more positive outcome, indicating enhanced HIV testing-related knowledge and practice among the participants.

Outcome measures

Outcome measures
Measure
Get a Learning Material and a Experiential HIV Testing
n=36 Participants
These participants in the experimental group will be provided a learning material about HIV testing, then an experiential HIV Testing, which includes HIV testing and counselling, education and discussion, and a post-test interviews will be provided. Experiential HIV Testing: The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.
Get a Learning Material Only
n=36 Participants
These participants in the control group will be provided a learning material about HIV testing only. After the post-test, the experiential HIV Testing will be provided to them.
HIV Testing Related Knowledge and Practice
pre-test
17.17 score on a scale
Standard Deviation 1.88
17.22 score on a scale
Standard Deviation 2.14
HIV Testing Related Knowledge and Practice
post-test
19.44 score on a scale
Standard Deviation 2.21
17.36 score on a scale
Standard Deviation 2.69

PRIMARY outcome

Timeframe: pre-test (Baseline) and post-test (Week 4)

The Healthcare Provider HIV/AIDS Stigma Scale (HPASS) will be used to assess this outcome. The instrument contains 30 items, each scored on a six-point Likert scale, yielding a minimum total score of 30 and a maximum of 180. Higher scores reflect greater levels of stigma toward people living with HIV, indicating a worse outcome. Validation of the HPASS through factor analysis identified three underlying dimensions. The stereotyping dimension (11 items; score range: 11-66) reflects negative cognitions and beliefs about people living with HIV. The prejudice dimension (13 items; score range: 13-78) captures emotionally driven attitudes. The discrimination dimension (6 items; score range: 6-36) represents behavioral responses stemming from negative attitudes. For all dimensions, higher scores indicate worse outcomes. These 3 dimensions(as sub-scale scores) for stereotyping, prejudice, and discrimination will also be calculated and analyzed.

Outcome measures

Outcome measures
Measure
Get a Learning Material and a Experiential HIV Testing
n=36 Participants
These participants in the experimental group will be provided a learning material about HIV testing, then an experiential HIV Testing, which includes HIV testing and counselling, education and discussion, and a post-test interviews will be provided. Experiential HIV Testing: The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.
Get a Learning Material Only
n=36 Participants
These participants in the control group will be provided a learning material about HIV testing only. After the post-test, the experiential HIV Testing will be provided to them.
HIV Related Stigma
(pre-test)HPASS in total
89.39 score on a scale
Standard Deviation 16.14
86.75 score on a scale
Standard Deviation 22.06
HIV Related Stigma
(post-test)HPASS in total
85.94 score on a scale
Standard Deviation 20.10
88.03 score on a scale
Standard Deviation 20.44
HIV Related Stigma
(pre-test)stereotyping
36.36 score on a scale
Standard Deviation 6.85
38.36 score on a scale
Standard Deviation 8.43
HIV Related Stigma
(post-test)stereotyping
36.31 score on a scale
Standard Deviation 7.66
38.03 score on a scale
Standard Deviation 9.20
HIV Related Stigma
(pre-test)prejudice
35.78 score on a scale
Standard Deviation 8.51
34.44 score on a scale
Standard Deviation 12.11
HIV Related Stigma
(post-test)prejudice
33.14 score on a scale
Standard Deviation 10.73
34.72 score on a scale
Standard Deviation 10.31
HIV Related Stigma
(pre-test)discrimination
17.25 score on a scale
Standard Deviation 5.61
13.94 score on a scale
Standard Deviation 5.68
HIV Related Stigma
(post-test)discrimination
16.50 score on a scale
Standard Deviation 5.59
15.28 score on a scale
Standard Deviation 5.32

Adverse Events

Get a Learning Material and a Experiential HIV Testing

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Get a Learning Material Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Piao-Yi Chiou

National Taiwan University

Phone: 02-2312-3456

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place